Morgan Stanley Reiterates Overweight on Alignment Healthcare, Maintains $19 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser has reiterated an Overweight rating on Alignment Healthcare (NASDAQ:ALHC) and maintained a $19 price target.
July 14, 2023 | 2:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley has reiterated an Overweight rating on Alignment Healthcare and maintained a $19 price target.
The reiteration of an Overweight rating by Morgan Stanley indicates a positive outlook for Alignment Healthcare. The maintained price target of $19 suggests that the analyst believes the stock is undervalued at current levels, which could lead to upward price movement in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100